Genocea Biosciences Inc ROCE
¿Qué es el ROCE de Genocea Biosciences Inc?
El ROCE de Genocea Biosciences Inc es -175.11%
¿Cuál es la definición de ROCE?
El retorno sobre el capital empleado (ROCE) es una relación financiera que mide la rentabilidad de una empresa y la eficiencia con la que se utiliza su capital.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE de compañías en Sector Health Care en NASDAQ en comparadas con Genocea Biosciences Inc
¿Qué hace Genocea Biosciences Inc?
Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.
Empresas con roce similar a Genocea Biosciences Inc
- UrbanGold Minerals tiene ROCE de -176.34%
- Elys Game Technology tiene ROCE de -176.22%
- Biohaven Ltd tiene ROCE de -175.96%
- Asiamet Resources tiene ROCE de -175.74%
- Elsight tiene ROCE de -175.70%
- Capricor Therapeutics Inc tiene ROCE de -175.51%
- Genocea Biosciences Inc tiene ROCE de -175.11%
- Sanibel Ventures tiene ROCE de -175.10%
- Workhorse Inc tiene ROCE de -174.48%
- Greenwich LifeSciences tiene ROCE de -173.92%
- Lordstown Motors tiene ROCE de -173.29%
- Satsuma Pharmaceuticals tiene ROCE de -172.20%
- Oncopeptides AB (publ) tiene ROCE de -172.14%